Innovative Diagnostics Driving Future Therapies
Blue Earth Diagnostics (blueearthdiagnostics.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 37th percentile of 12483 Healthcare brands.
Blue Earth Diagnostics is a molecular imaging company headquartered in Oxford, United Kingdom, founded in 2014. Backed by Bracco, it develops innovative diagnostic solutions aimed at providing early insight into cancer to support better clinical decision-making and future therapies. The company positions itself as a growth-focused leader in molecular imaging, serving healthcare providers, oncologists, radiologists, and patients seeking advanced diagnostic tools for cancer care.
| Brand Name | Blue Earth Diagnostics |
|---|---|
| Domain | blueearthdiagnostics.com |
| Industry | Healthcare |
| Founded | 2014 |
| Headquarters | Oxford |
| Parent Company / Owner | Bracco |
| Main Competitors | Lantheus Holdings (80/100), Curium Pharma (79/100), Telix Pharmaceuticals (75/100), Novartis (Advanced Accelerator Applications) (71/100), GE Healthcare (89/100), Siemens Healthineers (88/100) |
Moz Domain Authority 33/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Established molecular imaging company on a growth trajectory to provide innovative diagnostics solutions, driving future therapies in cancer." (Meta description: 18 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, HubSpot.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram, YouTube; no detected presence on X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Blue Earth Diagnostics?", Claude could identify the brand as of September 2026. Blue Earth Diagnostics is a radiopharmaceutical company specializing in molecular imaging agents, best known for developing PET imaging tracers used to detect and stage cancers such as prostate cancer. It was acquired by Bracco Diagnostics after initially being developed with bac Best known for Axumin, a PET imaging agent used to detect recurrent prostate cancer.
When asked "Best brands similar to Blue Earth Diagnostics?", Claude would recommend Blue Earth Diagnostics as of September 2026. It's a recognized name in oncology molecular imaging, particularly for prostate cancer PET tracers, so it's relevant if discussing diagnostic imaging companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Blue Earth Diagnostics's main competitors in Healthcare: Lantheus Holdings (80/100), Curium Pharma (79/100), Telix Pharmaceuticals (75/100), Novartis (Advanced Accelerator Applications) (71/100), GE Healthcare (89/100).
Sources: Brand Analyzer scan
Blue Earth Diagnostics has limited AI-search visibility, scoring 28/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 22, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Blue Earth Diagnostics official site
Blue Earth Diagnostics was founded in 2014. Blue Earth Diagnostics operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Blue Earth Diagnostics is headquartered in Oxford. Blue Earth Diagnostics operates in the Healthcare category.
Sources: Wikidata
Blue Earth Diagnostics scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Blue Earth Diagnostics official site
Blue Earth Diagnostics is a molecular imaging company based in Oxford, United Kingdom, founded in 2014. It is backed by Bracco and focuses on developing diagnostic solutions for cancer care, aiming to provide early insight into disease to support improved clinical decision-making and future cancer therapies.
Sources: Blue Earth Diagnostics official site
Blue Earth Diagnostics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Blue Earth Diagnostics official site
Blue Earth Diagnostics' offerings are used by healthcare providers, oncologists, and radiologists involved in cancer diagnosis and treatment planning, as well as by patients seeking advanced molecular imaging diagnostics as part of their cancer care.
Sources: Blue Earth Diagnostics official site
Blue Earth Diagnostics scores 28/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Blue Earth Diagnostics has a weak AI-visibility profile at 28/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 33/100 and thin schema.org structured data. In a live check, Claude could already identify Blue Earth Diagnostics from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Blue Earth Diagnostics: BiteFX (74/100), Birthing from Within (74/100), Blue Shield of California Foundation (74/100), Bob and Brad (74/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.